ORMP Oramed Pharmaceuticals Inc. - Common Stock
NASDAQ · Pharmaceuticals · Lihat di SEC EDGAR ↗ tutup Okt 2, 2026 10-K/10-Q Agu 10, 2026
$4,49
· % dari rentang 52 mgg
· di atas terendah
· ke tinggi
$2,09rendah 52m
$5,47tinggi 52m
Kapitalisasi Pasar (MRQ)
$186M
P/E
0.0
EPS
$1.50
Pendapatan
$2M
lencana Anda
Rentang 52M
$2–$5
Peringkat Analis
HOLD
Target Harga
$7
P/E
0.0
ROE
37.0%
Margin Laba Bersih
3202.5%
Strip lencana Anda kosong — sematkan metrik di mana saja di halaman ini.
ORMP Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$4.49
Kapitalisasi Pasar (MRQ)
$186M
P/E
0.0
EPS
$1.50
Pendapatan
$2M
ROE
37.0%
Rentang 52M
$2–$5
ORMP Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
rentang
batang
Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.
Pemecahan saham
| Tanggal ex-dividen | Pemecahan | Tipe |
|---|---|---|
| 23 Jan. 2013 | 1-for-12 | Terbalik |
Tentang Oramed Pharmaceuticals Inc. - Common Stock Tinjauan perusahaan dari Wikipedia
Oramed Pharmaceuticals Inc. (Hebrew: אורמד), is a publicly traded company engaged in the development of oral drug delivery systems – most notably an oral insulin capsule for treating type 2 diabetes. The company was founded in 2006 and is headquartered in Jerusalem. Its shares are listed on the NASDAQ Capital Market and the Tel Aviv Stock Exchange.
History
Oramed Pharmaceuticals was founded in 2006 by Miriam Kidron, a scientist at the Hadassah University Hospital in Jerusalem, and her son Nadav Kidron.
Product pipeline
Oramed considers its flagship product to be an oral insulin capsule developed to treat sufferers of type 2 diabetes. The Company is currently conducting Phase 3 trials, under the FDA, for oral insulin in Type 2 diabetes.
In addition to the oral insulin capsule, Oramed is developing an exenatide-based capsule designed to balance blood sugar levels and control appetite, and is conducting clinical trials for the treatment of NASH with oral insulin.
In 2021, Oramed created a subsidiary, Oravax Medical, to bring an oral Covid-19 vaccine to market.
In January 2023, a Phase 3 trial of Oramed's orally administered insulin for Type 2 diabetes patients failed, thus causing the share price to plunge. The company has mentioned that the pill worked for a subset of the population and will pursue a Phase 3 trial for that subset.
In May 2023, Ben Shapiro invested $4.7 million and was named to the board of directors.
On May 15, 2023, it was reported that Oramed's insulin pill was approved in China and will work with a Chinese firm to apply for marketing authorizations.
Subsidiaries
OraTech Pharmaceuticals is a joint venture formed by Oramed Pharmaceuticals and Hefei Tianhui Biotech, to commercialize its insulin capsule and is expected to list on the NASDAQ sometime in 2025.
Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗
sektorHealthcare
industriPharmaceuticals
negaraUS
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan$2M2017-08-31 → 2025-12-31
EPS$1.502022-12-31 → 2025-12-31
Arus Kas Bebas$-9M2019-08-31 → 2025-12-31
Margin bersih3202.5%2019-08-31 → 2025-12-31
Valuasi & Rasio
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
| Metrik | Tren 5 Tahun | ORMP | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| P/E | 0.0rata-rata 5T ≈0.1 | ≈0.1 | · | · | |
| P/S | 0.1rata-rata 5T ≈100.5 | ≈100.5 | · | · | |
| P/B (MRQ) | 0.6rata-rata 5T ≈1.4 | ≈1.4 | 1.2 | Kurang nilai | |
| Harga / FCF (TTM) | -35.6rata-rata 5T ≈-12.6 | ≈-12.6 | · | · | |
| Harga / Arus Kas (TTM) | -35.6rata-rata 5T ≈-12.8 | ≈-12.8 | · | · | |
| Price / Tangible Book (Harga / Nilai Buku Berwujud) | 0.0rata-rata 5T ≈1.2 | ≈1.2 | · | · |
Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
| Metrik | Tren 5 Tahun | ORMP | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Gross Margin (Margin Kotor) | 0.65% | · | · | · | |
| Operating Margin (Margin Operasi) | -754.4%rata-rata 5T ≈-1144.4% | ≈-1144.4% | -12.4% | Lemah | |
| EBITDA Margin (Margin EBITDA) | -754.4%rata-rata 5T ≈-1144.4% | ≈-1144.4% | 2.5% | Lemah | |
| Pretax Margin (Margin Sebelum Pajak) | 3766.2% | · | 38.2% | Tingkat teratas | |
| Net Profit Margin (Margin Laba Bersih) | 3202.5%rata-rata 5T ≈739.2% | ≈739.2% | 30.4% | Tingkat teratas | |
| ROA | 33.2%rata-rata 5T ≈4.6% | ≈4.6% | -1.5% | Tingkat teratas | |
| ROE | 37.0%rata-rata 5T ≈5.6% | ≈5.6% | -7.6% | Tingkat teratas | |
| ROIC | -6.4% | · | · | · |
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
| Metrik | Tren 5 Tahun | ORMP | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Rasio Lancar (MRQ) | 5.0rata-rata 5T ≈12.5 | ≈12.5 | 9.6 | Di bawah rata-rata | |
| Quick Ratio (Rasio Cepat) | 2.7rata-rata 5T ≈1.5 | ≈1.5 | 3.1 | Di bawah rata-rata |
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
| Metrik | Tren 5 Tahun | ORMP | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Revenue YoY (Pendapatan YoY) | -50.4% | · | · | · | |
| Revenue CAGR 3Y (CAGR Pendapatan 3T) | -9.6% | · | · | · |
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
| Metrik | Tren 5 Tahun | ORMP | rata-rata 5T | Median Rekan | Kesimpulan |
|---|---|---|---|---|---|
| Asset Turnover (Perputaran Aset) | 0.0rata-rata 5T ≈0.0 | ≈0.0 | 0.4 | Lemah |
nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median
Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun
| Tanggal ex-dividen | Jumlah | Mata Uang | Imbal Hasil |
|---|---|---|---|
| Jan 16, 2026 | $0,25 | USD | ≈6.8% |
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
472.3%
Laporan Berikutnya
Nov 11, 2026
| Periode | Laporan | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|---|
| 30 Juni 2026 | Agu 12, 2026 | $1.84 | $0.44 | 319.5% |
| 31 Des. 2025 | $0.24 | $0.00 | — | |
| 30 Sep. 2025 | $1.12 | $-0.04 | 2845.1% | |
| 30 Juni 2025 | $0.31 | $-0.04 | 859.8% | |
| 31 Maret 2025 | $-0.19 | $-0.01 | -1762.7% | |
| 31 Des. 2024 | $0.00 | $-0.03 | 100.0% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Laporan Laba Rugi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2M | · | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Cost of Revenue | $2M | · | · | · | · | · | $90.0K | $-86.0K | $187.0K | |
| Gross Profit | $13.0K | · | · | · | · | · | · | · | · | |
| R&D Expense | $6M | $6M | $9M | $28M | · | $10M | $14M | $12M | $10M | |
| SG&A Expense | $9M | $6M | $8M | $14M | · | $4M | $4M | $4M | $3M | |
| Operating Income | $-15M | $-13M | $-16M | $-41M | · | $-12M | $-15M | $-14M | $-11M | |
| Interest Expense | · | · | $2M | · | · | · | · | · | · | |
| Interest Income | · | · | $10.0K | · | · | · | · | · | · | |
| Other Non-op | $-606.0K | $-27.0K | $13.3K | $3M | · | · | · | · | · | |
| Pretax Income | $75M | $-16M | $5M | $-38M | · | $-12M | $-14M | $-13M | $-10M | |
| Income Tax | $11M | $3M | · | $100.0K | · | · | $300.0K | · | $400.0K | |
| Net Income | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| EPS (Basic) | $1.53 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| EPS (Diluted) | $1.50 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · | |
| Shares (Basic) | 41,402,997 | 40,850,446 | 40,315,068 | 38,997,649 | · | · | · | · | · | |
| Shares (Diluted) | 42,418,644 | 40,850,446 | 40,566,901 | 38,997,649 | · | · | · | · | · | |
| EBITDA | $-15M | · | $-16M | $-41M | · | $-12M | $-15M | · | · |
Neraca
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $46M | $54M | $9M | $40M | · | $19M | $3M | $5M | $4M | |
| Short-term Investments | $5M | $3M | · | · | $8M | $3M | · | $5M | · | |
| Prepaid Expense | $3M | $1M | $537.0K | $1M | · | $611.0K | $1M | $574.0K | · | |
| Current Assets | $133M | $143M | $163M | $157M | $148M | $41M | $33M | $31M | · | |
| PP&E (Net) | $586.0K | $698.0K | $873.0K | $815.0K | $388.0K | $99.0K | $24.0K | $17.0K | · | |
| Other Non-current Assets | $44.0K | $32.0K | $27.0K | · | · | · | · | · | · | |
| Total Assets | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Accounts Payable | $443.0K | $789.0K | $551.0K | $4M | $5M | $2M | $3M | $2M | · | |
| Accrued Liabilities | $1M | $402.0K | $605.0K | · | · | · | · | · | · | |
| Short-term Debt | $652.0K | $329.0K | $51M | · | · | · | $3M | $2M | · | |
| Current Liabilities | $19M | $6M | $53M | $6M | $7M | $5M | $5M | $5M | · | |
| Capital Leases | $540.0K | $156.0K | $342.0K | $647.0K | $370.0K | $31.0K | · | · | · | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | $60.0K | $63.0K | · | · | $211.0K | $271.0K | $313.0K | · | |
| Long-term Debt | · | · | · | $25.0K | $12M | · | $10M | $11M | · | |
| Total Debt | · | · | $51M | · | · | · | $3M | · | · | |
| Common Stock | $472.0K | $480.0K | $485.0K | $476.0K | $459.0K | $284.0K | $208.0K | $207.0K | · | |
| Paid-in Capital | · | · | · | $314M | $293M | $125M | · | · | · | |
| Retained Earnings | $-123M | $-177M | $-158M | $-163M | $-127M | $-93M | $-81M | $-69M | · | |
| AOCI | · | · | · | · | · | · | · | $702.0K | · | |
| Stockholders' Equity | $200M | $145M | $164M | $152M | $166M | $33M | $19M | $31M | $19M | |
| Liabilities + Equity | $231M | $155M | $221M | $162M | $178M | $45M | $35M | $47M | · | |
| Shares Outstanding | 39,275,006 | 39,920 | 40,339,000 | 39,564,000 | 38,158 | 23,675,530 | 17,383,359 | 17,369,875 | · |
Arus Kas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $4M | $4M | $12M | · | $465.0K | $808.0K | $2M | $2M | |
| Deferred Tax | $8M | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-9M | $-8M | $-10M | $-28M | · | $-12M | $-13M | $-15M | $-6M | |
| CapEx | $9.0K | $18.0K | $254.0K | $496.0K | · | $82.0K | $15.0K | $5.0K | $7.0K | |
| Investing Cash Flow | $5M | $106M | $-73M | $30M | · | $5M | $11M | $-7M | $4M | |
| Stock Issued | · | · | $2M | $12M | · | · | · | · | · | |
| Stock Repurchased | $5M | $2M | · | · | · | · | · | · | · | |
| Net Stock Activity | $-5M | · | $2M | $11M | · | · | · | · | · | |
| Financing Cash Flow | $-5M | $-52M | $52M | $11M | · | $24M | · | $23M | $2M | |
| Net Change in Cash | $-8M | $45M | $-31M | $13M | · | $16M | $-2M | $1M | $62.0K | |
| Taxes Paid | · | $2M | · | $2M | · | · | $300.0K | · | $400.0K | |
| Free Cash Flow | $-9M | · | $-11M | $-28M | · | $-13M | $-13M | · | · |
Profitabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 0.65% | · | · | · | · | · | · | · | · | |
| Operating Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| Net Margin | 3202.5% | · | 412.3% | -1397.1% | · | -424.8% | -531.1% | · | · | |
| Pretax Margin | 3766.2% | · | 379.7% | · | · | -424.8% | -520.0% | · | · | |
| EBITDA Margin | -754.4% | · | -1176.8% | -1502.0% | · | -433.8% | -541.3% | · | · | |
| ROA | 33.2% | · | 2.9% | -22.2% | · | -29.0% | -35.0% | · | · | |
| ROE | 37.0% | · | 3.5% | -23.7% | · | -47.0% | -70.1% | · | · | |
| ROIC | -6.4% | · | · | · | · | · | -67.6% | · | · |
Likuiditas & Solvabilitas
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.0 | · | 3.1 | 27.3 | · | 8.9 | 6.3 | · | · | |
| Quick Ratio | 2.7 | · | 1.3 | 0.7 | · | 5.0 | 1.3 | · | · | |
| Debt / Equity | · | · | 0.3 | · | · | · | 0.1 | · | · | |
| Interest Coverage | · | · | -7.7 | · | · | · | · | · | · |
Efisiensi
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | · | 0.0 | 0.0 | · | 0.1 | 0.1 | · | · |
Per Saham
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.09 | · | $4.06 | $3.84 | · | $1.39 | $1.12 | · | · | |
| Revenue / Share | $0.05 | · | $0.03 | $0.07 | · | · | · | · | · | |
| Cash Flow / Share | $-0.22 | · | $-0.25 | $-0.72 | · | · | · | · | · | |
| Cash / Share | $1.17 | · | $0.22 | · | · | $0.81 | $0.19 | · | · | |
| Dividend Paid / Share | $0.25 | · | · | · | · | · | · | · | · | |
| EPS (TTM) | $1.50 | $-0.48 | $0.14 | $-0.94 | · | · | · | · | · |
Tingkat Pertumbuhan
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | · | · | -50.4% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -9.6% | · | · | · | · | · | · | · | · |
Valuasi (TTM)
| Metrik | Tren | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2M | $3M | $1M | $3M | · | $3M | $3M | $2M | $2M | |
| Net Income TTM | $64M | $-19M | $5M | $-37M | · | $-12M | $-14M | $-13M | $-10M | |
| Market Cap | $112M | · | $93M | $476M | · | $83M | $58M | · | · | |
| Enterprise Value | · | · | $77M | · | · | · | $53M | · | · | |
| P/E | 1.9 | -5.0 | 16.5 | -12.8 | · | · | · | · | · | |
| P/S | 56.0 | · | 69.5 | 176.1 | · | 30.5 | 21.4 | · | · | |
| P/B | 0.6 | · | 0.6 | 3.1 | · | 2.5 | 3.0 | · | · | |
| P / Tangible Book | 0.6 | 0.7 | 0.6 | 3.1 | · | 2.5 | · | · | · | |
| P / Cash Flow | -12.2 | · | -9.1 | -17.0 | · | -6.6 | -4.5 | · | · | |
| P / FCF | -12.2 | · | -8.8 | -16.8 | · | -6.6 | -4.5 | · | · | |
| EV / EBITDA | · | · | -4.9 | · | · | · | -3.6 | · | · | |
| EV / FCF | · | · | -7.3 | · | · | · | -4.1 | · | · | |
| EV / Revenue | · | · | 57.8 | · | · | · | 19.8 | · | · | |
| Earnings Yield | 52.6% | -19.8% | 6.1% | -7.8% | · | · | · | · | · |
Laporan Laba Rugi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | · | · | $2M | · | · | · | · | $0 | · | $674.0K | $666.0K | $681.0K | $682.0K | |
| Cost of Revenue | · | · | $0 | · | · | $2M | · | · | · | · | · | · | · | · | · | · | |
| Gross Profit | · | · | $0 | · | · | $13.0K | · | · | · | · | · | · | · | · | · | · | |
| R&D Expense | · | $2M | $2M | $1M | $1M | $2M | $1M | $2M | $1M | $1M | $2M | $957.0K | $2M | $4M | $7M | $5M | |
| SG&A Expense | $3M | $2M | $4M | $1M | $1M | $2M | $2M | $847.0K | $2M | $2M | $2M | $3M | $2M | $1M | $3M | $3M | |
| Operating Expenses | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $11.0K | |
| Operating Income | $-3M | $-4M | $-6M | $-2M | $-2M | $-4M | $-4M | $-3M | $-3M | $-3M | $-4M | $-3M | $-4M | $-5M | $-10M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $592.0K | · | $826.0K | · | · | · | · | |
| Other Non-op | $-4.0K | $-100.0K | $-74M | $61M | · | $-143.0K | $-2M | $-15M | $14M | $4M | $-4M | $435.0K | $2M | $2M | $1M | $1M | |
| Pretax Income | $102M | $49M | $10M | $59M | $13M | $-7M | $-10M | $-19M | $11M | $2M | $13M | $-3M | $-1M | · | $-9M | $-7M | |
| Income Tax | $23M | $11M | $-212.0K | $11M | $-126.0K | $584.0K | $416.0K | $1M | $2M | · | · | · | · | · | $0 | $100.0K | |
| Net Income | $78M | $38M | $10M | $48M | $13M | $-8M | $-10M | $-20M | $9M | $2M | $13M | $-3M | $-1M | $-3M | $-8M | $-7M | |
| EPS (Basic) | $1.90 | $0.94 | $0.24 | $1.16 | $0.32 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| EPS (Diluted) | $1.84 | $0.91 | $0.25 | $1.13 | $0.31 | $-0.19 | $-0.26 | $-0.48 | $0.22 | $0.04 | $0.33 | $-0.08 | $-0.03 | $-0.08 | $-1.66 | $0.18 | |
| Shares (Basic) | 41,040,479 | 40,773,866 | · | 41,756,301 | 41,743,486 | 41,228,782 | · | 40,896,845 | 40,959,759 | 40,835,953 | · | 40,445,896 | 40,225,594 | 40,041,258 | · | 39,100,231 | |
| Shares (Diluted) | 42,501,252 | 41,970,186 | · | 42,774,504 | 42,609,425 | 41,228,782 | · | 40,896,845 | 41,591,007 | 41,564,007 | · | 40,445,896 | 40,225,594 | 40,041,258 | · | 39,100,231 | |
| EBITDA | $-3M | $-4M | · | $-2M | $-2M | $-4M | · | $-3M | $-3M | $-3M | · | $-3M | $-4M | $-5M | · | $-8M |
Neraca
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $15M | $13M | $46M | $52M | $16M | · | $54M | · | $10M | $19M | · | · | · | · | $40M | · | |
| Short-term Investments | $846.0K | $5M | $5M | $5M | $2M | $4M | $3M | $57M | $66M | $78M | · | $49.4K | $943.0K | $2M | · | $5M | |
| Prepaid Expense | $2M | $2M | $3M | $1M | $1M | $832.0K | $1M | $474.0K | $533.0K | $501.0K | $537.0K | $666.0K | $769.0K | · | $1M | · | |
| Current Assets | $53M | $68M | $133M | $136M | $99M | $131M | $143M | $143M | $153M | $177M | $163M | $176M | $151M | $155M | $157M | $160M | |
| PP&E (Net) | $532.0K | $561.0K | $586.0K | $614.0K | $645.0K | $671.0K | $698.0K | $718.0K | $765.0K | $819.0K | $873.0K | $923.0K | $945.0K | $977.0K | $815.0K | $535.0K | |
| Other Non-current Assets | $49.0K | $46.0K | $44.0K | $40.0K | $38.0K | $32.0K | $32.0K | · | · | · | $27.0K | · | · | · | · | · | |
| Total Assets | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Accounts Payable | $374.0K | $481.0K | $443.0K | $560.0K | $715.0K | $509.0K | $789.0K | $5M | $3M | $1M | $551.0K | $3M | $828.0K | $4M | $4M | $4M | |
| Accrued Liabilities | $1M | $1M | $1M | $585.0K | $841.0K | $800.0K | $402.0K | · | · | · | $605.0K | · | · | · | · | · | |
| Short-term Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | $51M | $75M | $3.0K | $1.0K | · | · | |
| Current Liabilities | $11M | $11M | $19M | $6M | $4M | $5M | $6M | $5M | $4M | $34M | $53M | $78M | $1M | $5M | $6M | $7M | |
| Capital Leases | $484.0K | $493.0K | $540.0K | $589.0K | $648.0K | $120.0K | $156.0K | $186.0K | $236.0K | $272.0K | $342.0K | $389.0K | $488.0K | $564.0K | $647.0K | $672.0K | |
| Deferred Tax | $40M | $18M | $8M | $8M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $60.0K | $60.0K | $60.0K | · | $63.0K | · | · | · | · | · | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | $75M | · | · | · | $5M | |
| Total Debt | · | · | · | $1.0K | $34.0K | $36.0K | · | · | · | $32M | · | $75M | $3.0K | $1.0K | · | · | |
| Common Stock | $495.0K | $491.0K | $472.0K | $490.0K | $491.0K | $491.0K | $480.0K | $484.0K | $488.0K | $487.0K | $485.0K | $484.0K | $484.0K | $481.0K | $476.0K | $470.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | $319M | $317M | · | $308M | |
| Retained Earnings | $-7M | $-85M | $-123M | $-123M | $-171M | $-184M | $-177M | $-166M | $-147M | $-156M | $-158M | $-171M | $-168M | $-166M | $-163M | $-155M | |
| Stockholders' Equity | $317M | $238M | $200M | $203M | $155M | $141M | $146M | $156M | $177M | $167M | $164M | $149M | $152M | $151M | $152M | $154M | |
| Liabilities + Equity | $370M | $269M | $231M | $220M | $162M | $148M | $155M | $165M | $184M | $204M | $221M | $231M | $156M | $160M | $162M | $164M | |
| Shares Outstanding | 41,314,211 | 40,926,081 | 39,275,006 | 40,838,226 | 40,845,087 | 40,850,455 | 39,919,545 | 40,209,575 | 40,628,924 | 40,519,160 | 40,338,979 | 40,282,688 | 40,219,396 | 39,969,979 | 39,563,888 | 39,113,236 |
Arus Kas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $1M | $2M | $2M | $719.0K | $800.0K | $2M | $1M | $301.0K | $1M | $1M | $1M | $852.0K | $2M | $173.0K | $3M | $3M | |
| Deferred Tax | $22M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-200.0K | $-3M | $-466.0K | $-2M | $-4M | $-4M | $-2M | $-7M | $2M | $-1M | $-1M | $-694.0K | $-3M | $-6M | $-8M | $-2M | |
| CapEx | $2.0K | $5.0K | $2.0K | $0 | $4.0K | $3.0K | $11.0K | $5.0K | $0 | $2.0K | $3.0K | $32.0K | $20.0K | $199.0K | $308.0K | $121.0K | |
| Investing Cash Flow | $4M | $-19M | $-2M | $38M | $-55M | $24M | $15M | $-34M | $95M | $30M | $30M | $-75M | $-15M | $-13M | $11M | $1M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $0 | $-2.0K | $0 | $2M | $4M | $-3M | |
| Stock Repurchased | · | · | $4M | $361.0K | · | · | $1M | · | · | · | · | · | · | · | · | · | |
| Dividends Paid | $78.0K | $10M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $-2M | $-10M | $-4M | $-361.0K | · | · | $-1M | $-1M | $-31M | $-19M | $-25M | $75M | $0 | $2M | $4M | $4M | |
| Net Change in Cash | $2M | $-33M | $-6M | $36M | $-59M | $20M | $12M | $-43M | $66M | $10M | $4M | $-1M | $-17M | $-16M | $7M | $3M | |
| Taxes Paid | · | · | · | $-7M | · | · | · | · | · | · | · | $527.0K | $3M | $308.0K | · | $167.0K | |
| Free Cash Flow | · | $-3M | · | · | · | $-4M | · | · | · | $-1M | · | · | · | $-6M | · | · |
Profitabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | · | 0.65% | · | · | · | · | · | · | · | · | · | · | |
| Operating Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| Net Margin | · | · | · | · | · | -382.1% | · | · | · | · | · | · | -177.2% | -542.2% | · | -1063.5% | |
| Pretax Margin | · | · | · | · | · | -352.9% | · | · | · | · | · | · | · | · | · | -1048.8% | |
| EBITDA Margin | · | · | · | · | · | -225.0% | · | · | · | · | · | · | -562.5% | -782.0% | · | -1200.7% | |
| ROA | 29.4% | 18.4% | · | 25.1% | 7.7% | -4.3% | · | -9.9% | 5.4% | 0.85% | · | -1.6% | -0.75% | -2.2% | · | -5.9% | |
| ROE | 33.1% | 20.2% | · | 26.9% | 8.0% | -5.0% | · | -12.8% | 5.6% | 0.97% | · | -2.1% | -0.78% | -2.3% | · | -6.5% | |
| ROIC | -0.67% | -1.2% | · | -0.97% | -1.6% | -3.5% | · | -2.1% | -1.5% | · | · | · | · | · | · | -5.4% |
Likuiditas & Solvabilitas
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 6.5 | · | 22.2 | 26.8 | 23.9 | · | 27.1 | 41.1 | 5.3 | · | 2.2 | 141.5 | 31.2 | · | 24.5 | |
| Quick Ratio | 1.5 | 1.7 | · | 9.3 | 4.8 | 0.7 | · | 10.9 | 20.4 | 2.9 | · | 0.0 | 0.9 | 0.5 | · | 0.8 | |
| Debt / Equity | · | · | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.2 | · | 0.5 | 0.0 | 0.0 | · | · | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -5.0 | · | -3.5 | · | · | · | · |
Efisiensi
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | · | 0.0 | · | · | · | · | · | · | 0.0 | 0.0 | · | 0.0 |
Per Saham
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $7.68 | $5.82 | · | $4.98 | $3.78 | $3.45 | · | $3.89 | $4.36 | $4.11 | · | $3.70 | $3.77 | $3.78 | · | $3.93 | |
| Revenue / Share | · | · | · | · | · | $0.05 | · | · | · | · | · | · | $0.02 | $0.02 | · | $0.02 | |
| Cash Flow / Share | · | $-0.07 | · | · | · | $-0.09 | · | · | · | $-0.04 | · | · | · | $-0.14 | · | · | |
| Cash / Share | $0.37 | $0.32 | · | $1.28 | $0.39 | · | · | · | $0.25 | $0.46 | · | · | · | · | · | · | |
| EPS (TTM) | $4.13 | $2.60 | · | $0.99 | $-0.62 | $-0.71 | · | $0.11 | $0.51 | $0.26 | · | $-1.85 | $-1.59 | $-1.29 | · | · |
Valuasi (TTM)
| Metrik | Tren | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | · | · | · | · | · | · | · | · | · | · | $3M | $3M | $3M | · | $3M | |
| Net Income TTM | $175M | $110M | · | $44M | $-24M | $-28M | · | $4M | $20M | $10M | · | $-16M | $-20M | $-29M | · | $-36M | |
| Market Cap | $199M | $139M | · | $108M | $92M | $87M | · | $98M | $104M | $118M | · | $105M | $144M | $87M | · | $253M | |
| Enterprise Value | · | · | · | $51M | $74M | · | · | · | · | $54M | · | · | · | · | · | · | |
| P/E | 1.2 | 1.3 | · | 2.7 | -3.6 | -3.0 | · | 22.2 | 5.0 | 11.2 | · | -1.4 | -2.3 | -1.7 | · | · | |
| P/S | · | · | · | · | · | · | · | · | · | · | · | 38.9 | 53.3 | 32.2 | · | 94.0 | |
| P/B | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Tangible Book | 0.6 | 0.6 | · | 0.5 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.7 | · | 0.7 | 1.0 | 0.6 | · | 1.6 | |
| P / Cash Flow | · | -47.7 | · | · | · | -24.8 | · | · | · | -80.2 | · | · | · | -15.7 | · | · | |
| Earnings Yield | 85.9% | 76.5% | · | 37.5% | -27.6% | -33.2% | · | 4.5% | 19.8% | 8.9% | · | -70.9% | -44.4% | -59.2% | · | · | |
| Payout Ratio | · | 27.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Pendapatan | $2M | · | $1M | $3M | · |
| Margin Kotor % | 0.65% | · | · | · | · |
| Margin Operasi % | -754.4% | · | -1176.8% | -1502.0% | · |
| Laba Bersih | $64M | $-19M | $5M | $-37M | · |
| EPS Dilusian | $1.50 | $-0.48 | $0.14 | $-0.94 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Utang / Ekuitas | · | · | 0.3 | · | · |
| Rasio Lancar | 7.0 | · | 3.1 | 27.3 | · |
| Rasio Cepat | 2.7 | · | 1.3 | 0.7 | · |
| Metrik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Arus Kas Bebas | $-9M | · | $-11M | $-28M | · |
Pemilik institusional (13F) 87 pengaju · $85.5M total · Per tanggal 30 Juni 2026
Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.
Pemegang
87
Nilai yang dipegang
$85.5M
Posisi baru
30
Posisi yang keluar
8
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
| Posisi baru | Posisi yang keluar | Meningkat | Menurun | Perubahan bersih saham |
|---|---|---|---|---|
| 30 (+13 vs Kuartal sebelumnya) | 8 (0 vs Kuartal sebelumnya) | 21 (+2 vs Kuartal sebelumnya) | 19 (+4 vs Kuartal sebelumnya) | +3.6M |
Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.
| Institusi | Nilai | Saham | % dari 13F yang dilacak | Tipe |
|---|---|---|---|---|
| MERCER GLOBAL ADVISORS INC /ADV | $18.328.697 | 3.810.540 | 21,43% | Saham |
| Aquamarine Financial (Cayman) Ltd | $12.083.562 | 2.512.175 | 14,13% | Saham |
| Gem Investment Advisors, LLC | $9.614.238 | 1.998.802 | 11,24% | Saham |
| BlackRock, Inc. | $7.735.015 | 1.608.111 | 9,04% | Saham |
| Murchinson Ltd. | $6.206.314 | 1.290.294 | 7,26% | Saham |
| SB Capital Management Inc | $5.415.000 | 1.900.000 | 6,33% | Saham |
| BML Capital Management, LLC | $4.166.754 | 866.269 | 4,87% | Saham |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.783.249 | 578.638 | 3,25% | Saham |
| GEODE CAPITAL MANAGEMENT, LLC | $2.408.318 | 500.690 | 2,82% | Saham |
| GOLDMAN SACHS GROUP INC | $1.218.339 | 253.293 | 1,42% | Saham |
| STATE STREET CORP | $1.164.501 | 242.100 | 1,36% | Saham |
| Rathbones Group PLC | $1.120.816 | 233.018 | 1,31% | Saham |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $1.105.732 | 229.882 | 1,29% | Saham |
| DIMENSIONAL FUND ADVISORS LP | $973.782 | 202.609 | 1,14% | Saham |
| NORTHERN TRUST CORP | $889.465 | 184.920 | 1,04% | Saham |
| RENAISSANCE TECHNOLOGIES LLC | $884.078 | 183.800 | 1,03% | Saham |
| WELLS FARGO & COMPANY/MN | $798.458 | 166.000 | 0,93% | Saham |
| BANK OF AMERICA CORP /DE/ | $724.838 | 150.694 | 0,85% | Saham |
| STRS OHIO | $643.578 | 133.800 | 0,75% | Saham |
| JANE STREET GROUP, LLC | $545.209 | 113.349 | 0,64% | Saham |
| O'SHAUGHNESSY ASSET MANAGEMENT, LLC | $495.247 | 102.962 | 0,58% | Saham |
| MARSHALL WACE, LLP | $490.393 | 101.953 | 0,57% | Saham |
| Hillsdale Investment Management Inc. | $429.533 | 89.300 | 0,50% | Saham |
| RITHOLTZ WEALTH MANAGEMENT | $405.709 | 84.347 | 0,47% | Saham |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $402.280 | 83.634 | 0,47% | Saham |
| Bank of New York Mellon Corp | $381.217 | 79.255 | 0,45% | Saham |
| UBS Group AG | $325.498 | 67.671 | 0,38% | Saham |
| AMERICAN CENTURY COMPANIES INC | $287.518 | 59.775 | 0,34% | Saham |
| XTX Topco Ltd | $240.130 | 49.923 | 0,28% | Saham |
| Nuveen, LLC | $223.203 | 46.404 | 0,26% | Saham |
| MORGAN STANLEY | $208.547 | 43.357 | 0,24% | Saham |
| CITADEL ADVISORS LLC | $199.927 | 41.565 | 0,23% | Saham |
| DEUTSCHE BANK AG\ | $159.682 | 33.198 | 0,19% | Saham |
| PRELUDE CAPITAL MANAGEMENT, LLC | $157.350 | 32.713 | 0,18% | Saham |
| BAILARD, INC. | $156.219 | 32.478 | 0,18% | Saham |
| RHUMBLINE ADVISERS | $147.281 | 30.621 | 0,17% | Saham |
| ALGERT GLOBAL LLC | $139.288 | 28.958 | 0,16% | Saham |
| Connor, Clark & Lunn Investment Management Ltd. | $121.246 | 25.207 | 0,14% | Saham |
| CITADEL ADVISORS LLC | $120.250 | 25.000 | 0,14% | Opsi beli |
| Invesco Ltd. | $119.052 | 24.751 | 0,14% | Saham |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $107.263 | 22.300 | 0,13% | Saham |
| MILLENNIUM MANAGEMENT LLC | $105.151 | 21.861 | 0,12% | Saham |
| PNC Financial Services Group, Inc. | $101.972 | 21.200 | 0,12% | Saham |
| Redwood Family Wealth LLC | $99.783 | 20.745 | 0,12% | Saham |
| Sage Capital Management, LLC | $86.474 | 17.977 | 0,10% | Saham |
| CITIGROUP INC | $76.037 | 15.808 | 0,09% | Saham |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $75.378 | 15.671 | 0,09% | Saham |
| VANGUARD FIDUCIARY TRUST CO | $67.811 | 14.098 | 0,08% | Saham |
| JPMORGAN CHASE & CO | $65.693 | 14.158 | 0,08% | Saham |
| Y-Intercept (Hong Kong) Ltd | $61.650 | 12.817 | 0,07% | Saham |
Aktivis & pemilik 5%+ 9 saham
Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.
| Pengaju | Diajukan | Kepemilikan | Status | Tujuan | Pengajuan |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. | 22 Juli 2026 | 3,30% | Amandemen | · | SEC |
| Nadav Kidron ×8 pengajuan | 28 Agu 2025 | 7,60% | Amandemen | · | SEC |
| Regals Capital Management LP, Regals Fund LP, David M. Slager ×2 pengajuan | 20 Juli 2018 | · | Pengajuan awal | · | SEC |
| Hefei Tianhui Incubator of Technologies Co., Ltd | 6 Jan. 2016 | · | Pengajuan awal | · | SEC |
| Leonard Sank | 15 Des. 2014 | · | Pengajuan awal | Investasi pasif | SEC |
| Miriam Kidron ×2 pengajuan | 3 Feb. 2014 | · | Pengajuan awal | · | SEC |
| Zeev Bronfeld | 6 Maret 2006 | · | Pengajuan awal | Investasi pasif | SEC |
| Orang pelapor yang tidak diungkapkan | 10 Juni 2004 | · | Pengajuan awal | · | SEC |
| Orang pelapor yang tidak diungkapkan | 10 Juni 2004 | · | Pengajuan awal | Investasi pasif | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Orang dalam perusahaan 30 orang dalam · 13 pejabat · 16 direktur
| Orang Dalam | Peran | Aktivitas terakhir | Saham dimiliki | Beli 12m | Jual 12m | Bersih 12m |
|---|---|---|---|---|---|---|
| Nadav Kidron | President and CEO | 24 Sep. 2026 D | 4.140.505 | 0 | 0 | $0 |
| Avraham Gabay | Chief Financial Officer | 1 Okt. 2026 S | 861.076 | 0 | 2 | $-421.054 |
| David Silberman | Chief Financial Officer | 4 Jan. 2024 A | 366.500 | 0 | 0 | $0 |
| Hilla Eisenberg | CFO, Treasurer and Secretary | 26 Feb. 2019 A | · | 0 | 0 | $0 |
| Yifat Hen Zommer | CFO, Treasurer and Secretary | 30 Juni 2017 A | 46.560 | 0 | 0 | $0 |
| Chaime Orlev | CFO, Treasurer and Secretary | 12 Okt. 2008 A | · | 0 | 0 | $0 |
| Joshua Hexter | COO & CBO | 1 Okt. 2026 S | 1.328.130 | 0 | 2 | $-746.320 |
| Miriam Kidron | Chief Scientific Officer | 24 Sep. 2026 D | 1.550.554 | 0 | 0 | $0 |
| Netanel Derovan | Chief Legal Officer | 26 Mei 2023 A | 149.500 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 3 Jan. 2023 S | 126.143 | 0 | 0 | $0 |
| Michael Rabinowitz | Chief Commercial Officer | 3 Jan. 2022 A | 109.468 | 0 | 0 | $0 |
| Mark Daniel Hasleton | VP Business Development | 26 Feb. 2019 A | · | 0 | 0 | $0 |
| Ronald Edward Law | Chief Strategy Officer | 20 Maret 2017 A | · | 0 | 0 | $0 |
| Yehuda Reznick | Direktur | 31 Des. 2025 A | 105.180 | 0 | 0 | $0 |
| Daniel Aghion | Direktur | 31 Des. 2025 A | 113.441 | 0 | 0 | $0 |
| Benjamin Shapiro | Direktur | 31 Des. 2025 A | 123.220 | 0 | 0 | $0 |
| Arie Mayer | Direktur | 31 Des. 2025 A | 168.009 | 0 | 0 | $0 |
| Leonard Sank | Direktur | 5 Juni 2025 A | 134.531 | 0 | 0 | $0 |
| Yadin Rozov | Direktur | 4 Jan. 2024 A | 155.320 | 0 | 0 | $0 |
| Kevin Rakin | Direktur | 21 Maret 2022 S | 46.661 | 0 | 0 | $0 |
| Aviad Friedman | Direktur | 3 Jan. 2022 G | 0 | 0 | 0 | $0 |
| Gao Xiaoming | Direktur | 8 Jan. 2020 A | · | 0 | 0 | $0 |
| David Mark Slager | Direktur | 15 April 2019 A | 1.316.328 | 0 | 0 | $0 |
| Xiaopeng Li | Direktur | 2 Agu 2017 P | 206.350 | 0 | 0 | $0 |
| Harold Jacob | Direktur | 10 Maret 2016 S | 16.396 | 0 | 0 | $0 |
| Michael Berelowitz | Direktur | 9 Des. 2015 S | 22.896 | 0 | 0 | $0 |
| Gerald M Ostrov | Direktur | 23 Feb. 2015 A | 24.896 | 0 | 0 | $0 |
| REGALS CAPITAL MANAGEMENT LP | Pemilik 10% | 23 Des. 2015 X | 1.186.823 | 0 | 0 | $0 |
| Zeev Bronfeld | Pemilik 10% | 27 Sep. 2011 S | 5.808.517 | 0 | 0 | $0 |
| Michael Young | · | 27 Mei 2004 S | 0 | 0 | 0 | $0 |
Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka
Kepemilikan ETF Dimiliki oleh 13 ETF
Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.
| Dana | Bobot | Unit | Per tanggal | Sumber |
|---|---|---|---|---|
| IWC · iShares Trust | 0,04% | 117.335 SH | 11 Sep. 2026 | Harian |
| OMFS · Invesco Exchange-Traded Self-Indexe… | 0,01% | 7.007 SH | 2 Okt. 2026 | Harian |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,01% | 29.637 SH | 19 Agu 2026 | Harian |
| RSSL · Global X Funds | 0,00% | 16.237 NS | 31 Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,00% | 622.970 SH | 11 Sep. 2026 | Harian |
| DFAS · Dimensional ETF Trust | 0,00% | 40.483 NS | 31 Juli 2026 | N-PORT |
| DCOR · Dimensional ETF Trust | 0,00% | 4.523 NS | 31 Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,00% | 36.536 NS | 31 Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 3.431 NS | 31 Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,00% | 196.765 SH | 19 Agu 2026 | Harian |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 3.480 SH | 19 Agu 2026 | Harian |
| DXUV · Dimensional ETF Trust | 0,00% | 4 NS | 31 Juli 2026 | N-PORT |
| IWN · iShares Trust | · | 316.654 SH | 11 Sep. 2026 | Harian |
ORMP Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
peringkat · 6 analis
JUAL
Target median
$7.00
+55,9%
0 0,0%
Beli Kuat
0 0,0%
Beli
3 50,0%
Tahan
1 16,7%
Jual
2 33,3%
Jual Kuat
Target Harga 12 Bulan
1 analis · 2026-09-29Target rata-rata $7.00 +55,9%
Rendah$7.00
Rata-rata$7.00
Tinggi$7.00
Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor
Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.
Sumber: SEC 10-Q diajukan Agu 10, 2026